Staidson (Beijing) Biopharmaceuticals Co., Ltd
Quick facts
Phase 3 pipeline
- BDB-001 injection · Oncology
BDB-001 injection is a monoclonal antibody targeting a specific molecular target. - STSA-1002 injection · Oncology
STSA-1002 injection is a monoclonal antibody targeting the PD-1 receptor. - STSP-0601 for Injection · Virology/Immunology
STSP-0601 is a recombinant human serum albumin-interferon alpha fusion protein that enhances antiviral and immunomodulatory responses.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: